Morgan Stanley’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.6M Buy
705,793
+54,061
+8% +$5.46M ﹤0.01% 1785
2025
Q4
$51.9M Sell
651,732
-782,910
-55% -$51.3M ﹤0.01% 2045
2025
Q3
$67M Buy
1,434,642
+383,605
+36% +$15M ﹤0.01% 1760
2025
Q2
$38.7M Sell
1,051,037
-204,650
-16% -$7.86M ﹤0.01% 2158
2025
Q1
$44.4M Buy
1,255,687
+397,409
+46% +$16.1M ﹤0.01% 1919
2024
Q4
$37.5M Buy
858,278
+205,460
+31% +$10.4M ﹤0.01% 2102
2024
Q3
$29.6M Sell
652,818
-342,671
-34% -$14.9M ﹤0.01% 2395
2024
Q2
$38.6M Buy
995,489
+68,419
+7% +$2.56M ﹤0.01% 1987
2024
Q1
$29.9M Sell
927,070
-2,379,278
-72% -$70.5M ﹤0.01% 2251
2023
Q4
$94.8M Buy
3,306,348
+2,504,375
+312% +$60.2M ﹤0.01% 1784
2023
Q3
$22.2M Sell
801,973
-181,522
-18% -$5.38M ﹤0.01% 2338
2023
Q2
$26.3M Buy
983,495
+598,758
+156% +$14.7M ﹤0.01% 2189
2023
Q1
$8.33M Buy
384,737
+46,761
+14% +$1.15M ﹤0.01% 3313
2022
Q4
$8.05M Buy
337,976
+86,212
+34% +$1.83M ﹤0.01% 3284
2022
Q3
$4.96M Buy
251,764
+9,734
+4% +$214K ﹤0.01% 3702
2022
Q2
$4.72M Buy
242,030
+54,261
+29% +$1.06M ﹤0.01% 3823
2022
Q1
$4.79M Buy
187,769
+138,843
+284% +$3.02M ﹤0.01% 3738
2021
Q4
$1.23M Sell
48,926
-51,057
-51% -$1.44M ﹤0.01% 4922
2021
Q3
$2.75M Sell
99,983
-426,435
-81% -$12.4M ﹤0.01% 4306
2021
Q2
$16.7M Buy
526,418
+367,073
+230% +$12.8M ﹤0.01% 2360
2021
Q1
$7.31M Buy
159,345
+129,118
+427% +$5.79M ﹤0.01% 3000
2020
Q4
$1.2M Sell
30,227
-21,957
-42% -$868K ﹤0.01% 4562
2020
Q3
$1.82M Buy
52,184
+22,431
+75% +$621K ﹤0.01% 3743
2020
Q2
$939K Sell
29,753
-17,751
-37% -$558K ﹤0.01% 4228
2020
Q1
$1.04M Buy
+47,504
New +$1.32M ﹤0.01% 3918

Other funds holding RVMD